Thank you for accepting our article entitled "A total EQD2 greater than 85 Gy for trachea and main bronchus D2cc being associated with severe late complications after definitive endobronchial brachytherapy" in your Journal, 'Journal of Contemporary Brachytherapy' last September. We erroneously considered that that work already passed our IRB review and permission was obtained at the time of submission. But it turned out that IRB review was still undergoing when I submitted the manuscript and the final decision of the IRB was reached on January 12^th^ 2016, which was after the publication. Therefore, could you kindly publish **erratum that the sentence "This retrospective study was approved by the institutional ethical review board of the National Cancer Center Hospital" should be omitted or that the sentence is changed to "this work is undergoing IRB review"**. We sincerely apologize you for my fault and appreciate you for your kind effort. We guarantee that all the findings and expressions except concerning IRB are true.
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